Yahoo
Stockholm - Delayed Quote SEK

Acarix AB (publ) (ACARIX.ST)

0.1798 -0.0004 (-0.22%)
At close: October 30 at 12:54:28 PM GMT+1
Chart Range Bar
Loading chart for ACARIX.ST
  • Previous Close 0.1802
  • Open 0.1828
  • Bid 0.1724 x --
  • Ask 0.1798 x --
  • Day's Range 0.1700 - 0.1848
  • 52 Week Range 0.1700 - 0.3445
  • Volume 877,877
  • Avg. Volume 1,357,645
  • Market Cap (intraday) 223.044M
  • Beta (5Y Monthly) -0.17
  • PE Ratio (TTM) --
  • EPS (TTM) -0.0400
  • Earnings Date --
  • Forward Dividend & Yield -- (0.00%)
  • Ex-Dividend Date --
  • 1y Target Est 0.40

Acarix AB (publ), a medical device company, develops solutions for rapid AI-based coronary artery disease rule-out. The company offers CADScor System, a point-of-care diagnostic aid that uses sensitive acoustics and advanced computational processing to support clinical decision making at the point of care. It sells its products in the Nordic countries, the United Kingdom, Germany, Switzerland, Austria, Mauritius, and the United States. The company was founded in 2009 and is headquartered in Malmö, Sweden.

www.acarix.com

8

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Medical Devices

Industry

Recent News

View More

Performance Overview

Trailing total returns as of 10/30/2026, which may include dividends or other distributions. Benchmark is OMX Stockholm 30 Index (^OMX) .

YTD Return

ACARIX.ST
32.91%
OMX Stockholm 30 Index (^OMX)
13.47%

1-Year Return

ACARIX.ST
32.28%
OMX Stockholm 30 Index (^OMX)
17.56%

3-Year Return

ACARIX.ST
26.76%
OMX Stockholm 30 Index (^OMX)
59.03%

5-Year Return

ACARIX.ST
81.19%
OMX Stockholm 30 Index (^OMX)
42.80%

Earnings Trends

View More

Earnings Per Share

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q2 FY26
Revenue 2.31M
Earnings --
Profit Margin 0.00%

Q3

FY25

Q4

FY25

Q1

FY26

Q2

FY26

0
500K
1M
2M
2M
0.0%

Analyst Insights

View More

Analyst Price Targets

0.40
0.40 Average
0.1798 Current
0.40 High

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    -48.33%

  • Return on Equity (ttm)

    -86.08%

  • Revenue (ttm)

    9.22M

  • Net Income Avi to Common (ttm)

    -39.38M

  • Diluted EPS (ttm)

    -0.0400

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    28.88M

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    -24M

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: